Achieving RA Treatment Goals: Real-World Experience and Emerging Insights into DMARD Monotherapy
WebcastFaculty
OVERVIEW
Achieving RA Treatment Goals: Real-World Experience and Emerging Insights into DMARD Monotherapy is organized by North American Center for Continuing Medical Education (NACCME) and will be held from Mar 29, 2018 - Mar 29, 2019.
The target audience for this medical event is designed for rheumatology professionals, including rheumatologists and rheumatology residents and fellows, along with the multidisciplinary team of NPs, PAs, and nurses. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits.
Course Description:
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form
Course Objectives:
• Discuss the impact of recent guidance on the role of monotherapy, sequencing, treat-to-target goals, and new therapies in RA management
• Explore recent real-world data and emerging insights into biologic and non-biologic DMARD monotherapy and the impact on treatment decisions
• Evaluate recent and emerging agents, including JAK inhibitors, and their role in the management of RA
• Develop personalized care plans utilizing evidence-based guidance, emerging data, treat-to-target, and shared decision-making strategies
Additional details will be posted as soon as they are available.
The target audience for this medical event is designed for rheumatology professionals, including rheumatologists and rheumatology residents and fellows, along with the multidisciplinary team of NPs, PAs, and nurses. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits.
Course Description:
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form
Course Objectives:
• Discuss the impact of recent guidance on the role of monotherapy, sequencing, treat-to-target goals, and new therapies in RA management
• Explore recent real-world data and emerging insights into biologic and non-biologic DMARD monotherapy and the impact on treatment decisions
• Evaluate recent and emerging agents, including JAK inhibitors, and their role in the management of RA
• Develop personalized care plans utilizing evidence-based guidance, emerging data, treat-to-target, and shared decision-making strategies
Additional details will be posted as soon as they are available.
FACULTY
SPECIALITIES
RheumatologyRELATED ONLINE COURSES
Quick Links